Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RELENT-1: Elinzanetant in Post-Menopausal Women With Vasomotor Symptoms
NCT02865538Phase 2Completed
- Sponsor
- Bayer
- Start
- Aug 2016
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of elinzanetant in vasomotor symptoms, sponsored by Bayer. Started Aug 2016; status: completed.
02
Drugs
elinzanetant
03
Conditions
vasomotor symptoms
Beyond the preview
Go deeper on NCT02865538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02865538.